8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer)
Published . Updated .
Key takeaways
- 8-K - Insight Molecular Diagnostics filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
- Exposed: IMDX
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
8-K - Insight Molecular Diagnostics filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
Directly affected
- IMDX Insight Molecular Diagnostics
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Insight Molecular Diagnostics belongs to, so it often moves with news about it.
- IDXX IDEXX Laboratories+33.6% 13d
IDEXX Laboratories is a peer of Insight Molecular Diagnostics in in vitro and in vivo diagnostic substances; rivals often move on the same news.
- LNTH Lantheus Holdings+1.3% 30d
Lantheus Holdings is a peer of Insight Molecular Diagnostics in in vitro and in vivo diagnostic substances; rivals often move on the same news.
- NEOG Neogen-6.5% 30d
Neogen is a peer of Insight Molecular Diagnostics in in vitro and in vivo diagnostic substances; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| IMDX | +47.44% | +18.59% | base | after close | after close | after close | after close |
| XLV | +3.66% | +3.71% | base | after close | after close | after close | after close |
| IDXX | -0.08% | +0.29% | base | after close | after close | after close | after close |
| LNTH | -0.74% | -0.25% | base | after close | after close | after close | after close |
| NEOG | +0.99% | -1.89% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-18 AccNo: 0001493152-26-053091 Size: 801 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Insight Molecular Diagnostics (IMDX) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| IDXX | three days earlier | +0.29% | final price |
| IDXX | five days earlier | -0.08% | final price |
| Insight Molecular Diagnostics (IMDX) | three days earlier | +18.59% | final price |
| Insight Molecular Diagnostics (IMDX) | five days earlier | +47.44% | final price |
| LNTH | three days earlier | -0.25% | final price |
| LNTH | five days earlier | -0.74% | final price |
| NEOG | three days earlier | -1.89% | final price |
| NEOG | five days earlier | +0.99% | final price |
| XLV | three days earlier | +3.71% | final price |
| XLV | five days earlier | +3.66% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Idexx Laboratories (IDXX) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Idexx Laboratories (IDXX) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 68 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Idexx Laboratories (IDXX) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 75 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Gilbert Cisneros sold Lantheus Holdings (LNTH), worth $1,001 - $15,000 on 15 Oct 2026. That is 34 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros sold Lantheus Holdings (LNTH), worth $1,001 - $15,000 on 14 Oct 2026. That is 35 days before publication. Filed 10 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Insight Molecular Diagnostics (IMDX)
Companies carried with this story
- IMDX Insight Molecular Diagnostics
In “8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer),” Insight Molecular Diagnostics (IMDX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> IMDX
Insight Molecular Diagnostics (IMDX)
The 18 Nov 2026 story “8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer)” names Insight Molecular Diagnostics (IMDX) because of this story.
For Insight Molecular Diagnostics (IMDX), the reason on file says SEC 8-K filing -> direct issuer disclosure -> IMDX
How strong the case is around Insight Molecular Diagnostics (IMDX)
14 out of 100
“8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.